Companies
Why healthcare, and why slowly
Demand we can predict ten years out, in businesses that must prove what they sell.
Healthcare attracts a particular kind of excitement: the breakthrough, the binary trial, the chart that goes vertical or to zero. That is exactly the part of it we stay away from.
What draws us is the dull middle. The diagnostics, the regulated suppliers, the businesses serving demand that is structural rather than fashionable. People will need these things in 2035 for reasons we can already read in the demographics. That kind of visibility is rare, and we pay up a little for it.
We move slowly here on purpose. Regulation rewards patience and punishes the hurried. An approval is worth waiting for, and a shortcut is rarely worth taking. We are happy to underwrite a decade of steady, defensible demand. We are not equipped, or inclined, to bet on the next miracle.
The views above are the firm's own and are provided for information only. They are not investment advice, nor an offer or solicitation to invest. Capital at risk; the value of investments can go down as well as up, and past performance is not a guide to future results.
More on companies